Brittany Stewart1, Aaron Brody2, Abhinav C Krishnan3, Sara K Brown4, Phillip D Levy2. 1. Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Ave., Detroit, MI, 48201, USA. brittanystewart@wayne.edu. 2. Department of Emergency Medicine and Integrative Biosciences Center, Wayne State University, 6135 Woodward Ave., Detroit, MI, 48202, USA. 3. Department of Physiology and Integrative Biosciences Center, Wayne State University, 6135 Woodward Ave., Detroit, MI, 48202, USA. 4. Meijer Pharmacy/Wayne State University Community-based Pharmacy Practice Resident, 13000 Middlebelt Rd., Livonia, MI, 48150, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to describe the role of the pharmacist in innovative pathways of care for hypertension (HTN) management for emergency department (ED) patients, particularly in under-resourced communities. Due to intersecting socioeconomic and personal health risk factors, these patients bear a disproportionate share of cardiovascular disease, yet often have limited access to high-quality primary care. RECENT FINDINGS: Recent meta-analyses demonstrate a clear advantage associated with pharmacist-physician collaborative models over traditional physician-only care in achieving blood pressure control. However, no prior study has evaluated use of pharmacist-led follow-up for ED patients with uncontrolled blood pressure (BP). Thus, we developed a pharmacist-driven transitional care clinic (TCC) that utilizes a collaborative practice agreement with ED physicians to improve HTN management for ED patients. We have successfully implemented the TCC in a high-volume urban ED and in a pilot study have shown clinically relevant BP reductions with our collaborative model. The use of pharmacist-led follow-up for HTN management is highly effective. Novel programs such as our TCC, which extend the reach of such a model to ED patients, are promising, and future studies should focus on implementation through larger, multicenter, randomized trials. However, to be most effective, policy advocacy is needed to expand pharmacist prescriptive authority and develop innovative financial models to incentivize this practice.
PURPOSE OF REVIEW: The purpose of this review is to describe the role of the pharmacist in innovative pathways of care for hypertension (HTN) management for emergency department (ED) patients, particularly in under-resourced communities. Due to intersecting socioeconomic and personal health risk factors, these patients bear a disproportionate share of cardiovascular disease, yet often have limited access to high-quality primary care. RECENT FINDINGS: Recent meta-analyses demonstrate a clear advantage associated with pharmacist-physician collaborative models over traditional physician-only care in achieving blood pressure control. However, no prior study has evaluated use of pharmacist-led follow-up for ED patients with uncontrolled blood pressure (BP). Thus, we developed a pharmacist-driven transitional care clinic (TCC) that utilizes a collaborative practice agreement with ED physicians to improve HTN management for ED patients. We have successfully implemented the TCC in a high-volume urban ED and in a pilot study have shown clinically relevant BP reductions with our collaborative model. The use of pharmacist-led follow-up for HTN management is highly effective. Novel programs such as our TCC, which extend the reach of such a model to ED patients, are promising, and future studies should focus on implementation through larger, multicenter, randomized trials. However, to be most effective, policy advocacy is needed to expand pharmacist prescriptive authority and develop innovative financial models to incentivize this practice.
Entities:
Keywords:
Collaborative practice agreement; Emergency department; Hypertension; Pharmacist
Authors: Sassan Naderi; Barbara Barnett; Robert S Hoffman; Resul Dalipi; Lauren Houdek; Kumar Alagappan; Robert Silverman Journal: Am J Emerg Med Date: 2011-11-12 Impact factor: 2.469
Authors: Jill F Lehrmann; Paula Tanabe; Brigitte M Baumann; Molly K Jones; Zoran Martinovich; James G Adams Journal: Acad Emerg Med Date: 2007-09-26 Impact factor: 3.451
Authors: Brigitte M Baumann; David M Cline; John J Cienki; Darcy Egging; Jill F Lehrmann; Paula Tanabe Journal: Am J Hypertens Date: 2009-03-05 Impact factor: 2.689
Authors: Brigitte M Baumann; Nicole L Abate; Robert M Cowan; Michael E Chansky; Karena Rosa; Edwin D Boudreaux Journal: Acad Emerg Med Date: 2007-07-25 Impact factor: 3.451